Literature DB >> 2848797

The action of stimulant medication in attention deficit disorder with hyperactivity: dopaminergic, noradrenergic, or both?

F Levy, G Hobbes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 2848797     DOI： 10.1097/00004583-198811000-00025

Source DB:  PubMed          Journal:  J Am Acad Child Adolesc Psychiatry        ISSN： 0890-8567            Impact factor:   8.829


× No keyword cloud information.
  4 in total

Review 1.  Pharmacokinetic and pharmacodynamic drug interactions in the treatment of attention-deficit hyperactivity disorder.

Authors:  J S Markowitz; K S Patrick
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

2.  Does haloperidol block methylphenidate? Motivation or attention?

Authors:  F Levy; G Hobbes
Journal:  Psychopharmacology (Berl)       Date:  1996-07       Impact factor: 4.530

3.  Cell-Type Specific Deletion of CB2 Cannabinoid Receptors in Dopamine Neurons Induced Hyperactivity Phenotype: Possible Relevance to Attention-Deficit Hyperactivity Disorder.

Authors:  Ana Canseco-Alba; Branden Sanabria; Mariam Hammouda; Rollanda Bernadin; Marizel Mina; Qing-Rong Liu; Emmanuel S Onaivi
Journal:  Front Psychiatry       Date:  2022-02-08       Impact factor: 4.157

4.  Pharmacological and therapeutic directions in ADHD: Specificity in the PFC.

Authors:  Florence Levy
Journal:  Behav Brain Funct       Date:  2008-02-28       Impact factor: 3.759
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.